HighTower Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.18M | Sell |
106,580
-11,484
| -10% | -$765K | 0.01% | 1060 |
|
|
2026
Q1 | $7.41M | Sell |
118,064
-3,633
| -3% | -$253K | 0.01% | 1009 |
|
|
2025
Q4 | $8.08M | Buy |
121,697
+68,251
| +128% | +$4.41M | 0.01% | 954 |
|
|
2025
Q3 | $3.6M | Sell |
53,446
-21,822
| -29% | -$1.73M | ﹤0.01% | 1297 |
|
|
2025
Q2 | $6.57M | Buy |
75,268
+1,604
| +2% | +$126K | 0.01% | 982 |
|
|
2025
Q1 | $5.03M | Buy |
73,664
+1,690
| +2% | +$138K | 0.01% | 1046 |
|
|
2024
Q4 | $5.6M | Sell |
71,974
-15,134
| -17% | -$1.12M | 0.01% | 1005 |
|
|
2024
Q3 | $5.82M | Buy |
87,108
+18,445
| +27% | +$1.51M | 0.01% | 970 |
|
|
2024
Q2 | $7.74M | Sell |
68,663
-23,505
| -26% | -$2.97M | 0.01% | 819 |
|
|
2024
Q1 | $12.8M | Buy |
92,168
+33,176
| +56% | +$4.17M | 0.02% | 600 |
|
|
2023
Q4 | $7.29M | Sell |
58,992
-15,836
| -21% | -$1.62M | 0.01% | 809 |
|
|
2023
Q3 | $6.98M | Buy |
74,828
+10,780
| +17% | +$1.22M | 0.01% | 783 |
|
|
2023
Q2 | $8.24M | Buy |
64,048
+4,243
| +7% | +$513K | 0.02% | 710 |
|
|
2023
Q1 | $6.95M | Buy |
59,805
+1,437
| +2% | +$161K | 0.02% | 727 |
|
|
2022
Q4 | $6.59M | Sell |
58,368
-6,152
| -10% | -$675K | 0.02% | 740 |
|
|
2022
Q3 | $5.2M | Sell |
64,520
-6,074
| -9% | -$514K | 0.01% | 790 |
|
|
2022
Q2 | $5.26M | Sell |
70,594
-11,718
| -14% | -$1.07M | 0.01% | 795 |
|
|
2022
Q1 | $10.6M | Sell |
82,312
-10,924
| -12% | -$1.19M | 0.02% | 601 |
|
|
2021
Q4 | $12.6M | Buy |
93,236
+22,200
| +31% | +$3.19M | 0.03% | 520 |
|
|
2021
Q3 | $9.73M | Sell |
71,036
-24,744
| -26% | -$3.12M | 0.03% | 543 |
|
|
2021
Q2 | $10.2M | Sell |
95,780
-16,096
| -14% | -$1.55M | 0.03% | 512 |
|
|
2021
Q1 | $10.1M | Sell |
111,876
-88,284
| -44% | -$8.29M | 0.03% | 479 |
|
|
2020
Q4 | $18.5M | Buy |
200,160
+84,636
| +73% | +$7.56M | 0.08% | 252 |
|
|
2020
Q3 | $11.9M | Sell |
115,524
-50,244
| -30% | -$5.25M | 0.06% | 301 |
|
|
2020
Q2 | $16.8M | Sell |
165,768
-34,728
| -17% | -$3.11M | 0.09% | 224 |
|
|
2020
Q1 | $13.5M | Sell |
200,496
-41,180
| -17% | -$2.56M | 0.09% | 223 |
|
|
2019
Q4 | $13.2M | Sell |
241,676
-54,128
| -18% | -$2.57M | 0.08% | 264 |
|
|
2019
Q3 | $11M | Buy |
295,804
+131,604
| +80% | +$5.11M | 0.06% | 312 |
|
|
2019
Q2 | $6.15M | Buy |
164,200
+37,520
| +30% | +$1.18M | 0.04% | 486 |
|
|
2019
Q1 | $3.78M | Sell |
126,680
-114,712
| -48% | -$4.03M | 0.03% | 617 |
|
|
2018
Q4 | $7.24M | Buy |
241,392
+23,200
| +11% | +$736K | 0.06% | 354 |
|
|
2018
Q3 | $7.84M | Sell |
218,192
-56,636
| -21% | -$1.76M | 0.06% | 360 |
|
|
2018
Q2 | $6.48M | Sell |
274,828
-240,696
| -47% | -$5.1M | 0.05% | 409 |
|
|
2018
Q1 | $9.53M | Buy |
515,524
+207,352
| +67% | +$3.07M | 0.08% | 270 |
|
|
2017
Q4 | $4.4M | Sell |
308,172
-43,628
| -12% | -$567K | 0.04% | 514 |
|
|
2017
Q3 | $4.31M | Buy |
351,800
+190,168
| +118% | +$3.36M | 0.04% | 513 |
|
|
2017
Q2 | $2.96M | Buy |
161,632
+26,172
| +19% | +$483K | 0.03% | 653 |
|
|
2017
Q1 | $2.85M | Buy |
135,460
+7,796
| +6% | +$152K | 0.03% | 627 |
|
|
2016
Q4 | $1.91M | Buy |
127,664
+94,748
| +288% | +$1.68M | 0.02% | 718 |
|
|
2016
Q3 | $725K | Sell |
32,916
-1,788
| -5% | -$39.8K | 0.01% | 1055 |
|
|
2016
Q2 | $691K | Sell |
34,704
-33,024
| -49% | -$562K | 0.01% | 1024 |
|
|
2016
Q1 | $1.15M | Sell |
67,728
-17,420
| -20% | -$291K | ﹤0.01% | 960 |
|
|
2015
Q4 | $1.74M | Buy |
85,148
+51,864
| +156% | +$1.08M | 0.02% | 694 |
|
|
2015
Q3 | $711K | Sell |
33,284
-2,480
| -7% | -$55.3K | 0.01% | 1055 |
|
|
2015
Q2 | $718K | Buy |
35,764
+4,440
| +14% | +$78K | 0.01% | 885 |
|
|
2015
Q1 | $488K | Buy |
31,324
+10,324
| +49% | +$156K | 0.01% | 1079 |
|
|
2014
Q4 | $289K | Buy |
+21,000
| New | +$257K | ﹤0.01% | 1247 |
|
Other funds holding DXCM
HighTower Advisors's DXCM Position: Q2 2026 in Review
HighTower Advisors reduced its DexCom (DXCM) stake by 9.7% in Q2 2026, selling an estimated $765K and leaving 106,580 shares worth $7.18M. The position accounts for 0.01% of the portfolio, ranked #1060.
HighTower Advisors first reported a position in DXCM in Q4 2014 and has held it in 47 quarters since. The position peaked at $18.5M in Q4 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- HighTower Advisors held 106,580 shares of DexCom worth $7.18M as of Q2 2026.
- HighTower Advisors sold 11,484 DexCom shares in Q2 2026, an estimated $765K.
- DexCom made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1060 holding.
- HighTower Advisors first reported a position in DexCom in Q4 2014 and has held it in 47 quarters since.
- HighTower Advisors's DexCom position peaked at $18.5M in Q4 2020.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.